5 Stock Picks of Rishi Bajaj’s Altai Capital

2. Pardes Biosciences, Inc. (NASDAQ:PRDS)

Altai Capital’s Stake Value: $1,637,000
Percentage of Altai Capital’s 13F Portfolio: 0.71%
Number of Hedge Fund Holders: 18

Pardes Biosciences, Inc. (NASDAQ:PRDS) is a bio-pharmaceutical business in the clinical stage. Roanna Ruiz of SVB Leerink initiated coverage of Pardes Biosciences, Inc. (NASDAQ:PRDS) on March 15, maintaining an Outperform rating and assigning a price target of $18.

Rishi Bajaj’s Altai Capital initiated a new stake in Pardes Biosciences, Inc. (NASDAQ:PRDS) in the fourth quarter of 2021 by purchasing 100,000 shares of the bio-pharmaceutical company, worth $1.64 million.

By the end of the fourth quarter of 2021, Insider Monkey identified 18 hedge funds with stakes in Pardes Biosciences, Inc. (NASDAQ:PRDS). These stakes were worth a total of $219.88 million.